Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)
Germany flag Germany · Delayed Price · Currency is EUR
0.9700
-0.0050 (-0.51%)
Last updated: Apr 25, 2025

FRA:TQR Statistics

Total Valuation

FRA:TQR has a market cap or net worth of EUR 815.76 million. The enterprise value is 641.23 million.

Market Cap 815.76M
Enterprise Value 641.23M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date Apr 29, 2025
Ex-Dividend Date May 30, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 237.04M

Valuation Ratios

The trailing PE ratio is 13.11.

PE Ratio 13.11
Forward PE n/a
PS Ratio 4.07
PB Ratio 1.54
P/TBV Ratio 1.64
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 10.31
EV / Sales 3.51
EV / EBITDA 9.54
EV / EBIT 9.81
EV / FCF n/a

Financial Position

The company has a current ratio of 16.85, with a Debt / Equity ratio of 0.03.

Current Ratio 16.85
Quick Ratio 10.02
Debt / Equity 0.03
Debt / EBITDA 0.21
Debt / FCF n/a
Interest Coverage 88.58

Financial Efficiency

Return on equity (ROE) is 12.80% and return on invested capital (ROIC) is 8.42%.

Return on Equity (ROE) 12.80%
Return on Assets (ROA) 7.98%
Return on Invested Capital (ROIC) 8.42%
Return on Capital Employed (ROCE) 13.28%
Revenue Per Employee 256,279
Profits Per Employee 79,553
Employee Count 782
Asset Turnover 0.36
Inventory Turnover 0.42

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.19% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -10.19%
50-Day Moving Average 0.99
200-Day Moving Average 0.98
Relative Strength Index (RSI) 47.52
Average Volume (20 Days) 800

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:TQR had revenue of EUR 200.41 million and earned 62.21 million in profits. Earnings per share was 0.07.

Revenue 200.41M
Gross Profit 132.48M
Operating Income 71.39M
Pretax Income 78.31M
Net Income 62.21M
EBITDA 73.46M
EBIT 71.39M
Earnings Per Share (EPS) 0.07
Full Income Statement

Balance Sheet

The company has 227.93 million in cash and 15.35 million in debt, giving a net cash position of 212.58 million.

Cash & Cash Equivalents 227.93M
Total Debt 15.35M
Net Cash 212.58M
Net Cash Per Share n/a
Equity (Book Value) 528.05M
Book Value Per Share 0.61
Working Capital 463.88M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.10%, with operating and profit margins of 35.62% and 31.04%.

Gross Margin 66.10%
Operating Margin 35.62%
Pretax Margin 39.08%
Profit Margin 31.04%
EBITDA Margin 36.65%
EBIT Margin 35.62%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 4.06%.

Dividend Per Share 0.04
Dividend Yield 4.06%
Dividend Growth (YoY) -44.29%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 4.06%
Earnings Yield 7.63%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:TQR has an Altman Z-Score of 17.27.

Altman Z-Score 17.27
Piotroski F-Score n/a